Restoration Biologics secured exclusive global rights to Akos' cannabinoid-COX-2 conjugate compounds for human and animal applications. Enveric may receive up to $82 million in milestone payments ...
Stock futures inched up on Tuesday, recovering from the previous day’s market turbulence caused by concerns over DeepSeek. Attention now shifts to the Federal Reserve, which begins its two-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback